Learning Objectives:
1. Interpret the data available regarding methylphenidate in the treatment of cancer related fatigue.
2. Identify patients who may benefit from methylphenidate.
3. Adopt practices for treatment of cancer related fatigue.
4. Discuss factors contributing to non-concordance between end-of-life care and advance care planning
5. Provide critique of methods of research in studying non-concordance between end-of-life care and advance care planning.
6. Discuss how research in non-concordance between end-of-life care and advance care planning may be applied to UCMC patient population.
Session date:
10/03/2024 - 8:00am to 9:00am CDT
Location:
W719
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Quoc-Duy Dinh, MD and Adam Hockensmith, MD